Lucid Diagnostics Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Lucid Diagnostics Inc. (LUCD) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $50.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-12
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $50.00K.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $34.00K, a 98.55% decline from fiscal 2024.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.35M, a 517.63% increase from fiscal 2023.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $380.00K, a 86.25% decline from fiscal 2022.
- Lucid Diagnostics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.76M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $50.00K 10-Q · filed 2026-08-12 | $50.00K derived: sum of 3 quarters · filed 2026-08-12 | $50.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $34.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $34.00K 10-Q · filed 2025-11-12 | $34.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $34.00K 10-Q · filed 2026-08-12 | $34.00K derived: sum of 3 quarters · filed 2026-08-12 | $96.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-13 | $34.00K derived: sum of 2 quarters · filed 2026-05-13 | $96.00K derived: sum of 3 quarters · filed 2026-05-13 | $2.36M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $62.00K derived: sum of 2 quarters · filed 2026-03-25 | $2.33M derived: sum of 3 quarters · filed 2026-03-25 | $2.35M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.33M derived: sum of 2 quarters · filed 2025-11-12 | $2.35M 10-Q · filed 2025-11-12 | $2.35M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.29M 10-Q · filed 2025-08-12 | $2.29M derived: sum of 3 quarters · filed 2025-08-12 | $2.34M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $22.00K 10-Q · filed 2025-05-13 | $22.00K derived: sum of 2 quarters · filed 2025-05-13 | $81.00K derived: sum of 3 quarters · filed 2025-05-13 | $277.00K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $59.00K derived: sum of 2 quarters · filed 2025-03-24 | $255.00K derived: sum of 3 quarters · filed 2025-03-24 | $380.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $255.00K derived: sum of 2 quarters · filed 2024-11-12 | $380.00K 10-Q · filed 2024-11-12 | $576.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $321.00K 10-Q · filed 2024-08-12 | $341.00K 10-Q · filed 2023-08-14 | $517.00K derived: sum of 3 quarters · filed 2024-08-12 | $636.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $125.00K 10-Q · filed 2024-05-13 | $321.00K derived: sum of 2 quarters · filed 2024-05-13 | $440.00K derived: sum of 3 quarters · filed 2024-05-13 | $484.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $315.00K derived: sum of 2 quarters · filed 2024-03-25 | $359.00K derived: sum of 3 quarters · filed 2024-03-25 | $2.76M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $163.00K derived: sum of 2 quarters · filed 2023-11-13 | $2.57M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.45M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $2.40M 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |